NDC 49884-778 - Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49884-778
- Manufacturer
- Contract Pharmacy Services-PA
- Effective date
- 2009-10-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen - Contract Pharmacy Services-PA | Contract Pharmacy Services-PA | 2009-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dolce and Gabbana Everlast Foundation SPF 20 09C Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 897024cd-576e-4a8e-8daa-92dc3bb4b3a5 | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 11W Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 303967d1-9df8-4a8e-a264-6b0d8fdbf2a8 | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 12N Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 26062cd7-3817-46c7-b65f-92cd57eca5dd | 2025-08-05 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 13C Light Medium | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 448a24a3-91ef-4530-828c-e77d8aae7f0b | 2025-08-05 | Warnings | 15FIX9V2JP |
| Schuessler Tissue Salts Silica Cleanser and Conditioner 12 | SILICEA | Martin & Pleasance Pty Ltd | f70dcf90-bde9-404d-9ede-4113553ccbff | 2025-08-04 | Warnings | ETJ7Z6XBU4 |
| Dolce and Gabbana Everlast Foundation SPF 20 02C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 09f9e59b-6f71-4d42-9b5d-275f756d985b | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 03W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3b1e4480-8409-425e-b98d-eb4dcf2471e8 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 06W Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | 3090422e-fc18-45b8-88f2-6a9b282a7205 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 05N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f93aa5d2-90ab-4e11-874e-2ede4b25c4b6 | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 04C Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | f055cd51-7b1d-43df-8990-8f60ba1eb91c | 2025-08-04 | Warnings | 15FIX9V2JP |
| Dolce and Gabbana Everlast Foundation SPF 20 07N Light | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | Dolce & Gabbana Beauty S.R.L | d4c76bc5-205b-45fd-8a02-4f4b17458503 | 2025-08-04 | Warnings | 15FIX9V2JP |
| CHILDRENS IBUPROFEN | IBUPROFEN | Meijer, Inc. | eed4f13d-4bee-4ccc-a651-a6f86d6d1f7b | 2025-08-04 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Asclemed USA, Inc. | d7ed42c4-371c-4a54-ab15-0630656f0427 | 2025-08-02 | Boxed warning, Warnings, Adverse reactions | 197807 WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PHOENIX RX LLC | 3b17587e-b609-42a9-e063-6294a90ab1f8 | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | 197807 WK2XYI10QM |
| Childrens Ibuprofen Oral Suspension | IBUPROFEN | PAI Holdings, LLC dba PAI Pharma | c26cefe0-182a-4b03-baeb-b3eb2e0e2267 | 2025-08-01 | Warnings | WK2XYI10QM |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | Preferred Pharmaceuticals Inc. | e2f29ca9-9ec8-4b82-8c80-8628d9e3ab2f | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Acetaminophen, Ibuprofen | ACETAMINOPHEN, IBUPROFEN | GLENMARK THERAPEUTICS INC., USA | 57a8dc2b-a3bc-49fa-b605-2330155bdbff | 2025-07-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 0e95aab9-3a7c-49c3-b8df-f66d6f31aee0 | 2025-07-31 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Rite Aid Corporation | 47657d95-4a54-49c2-8273-86b413b8f41e | 2025-07-30 | Warnings | WK2XYI10QM |
| Neutrogena Mineral Invisible Daily Defense Face Sunscreen Broad Spectrum SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | Kenvue Brands LLC | 003123d2-9675-fdd2-e063-6294a90a0130 | 2025-07-28 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.